Eder M - Search Results

1

Effects of Flt3 ligand and interleukin-7 on in vitro growth of acute lymphoblastic leukemia cells.

Eder M, Hemmati P, Kalina U, Ottman OG, Hoelzer D, Lyman SD, Ganser A. Eder M, et al. Exp Hematol. 1996 Feb;24(2):371-7. Exp Hematol. 1996. PMID: 8641368

2

In vitro culture of common acute lymphoblastic leukemia blasts: effects of interleukin-3, interleukin-7, and accessory cells.

Eder M, Ottmann OG, Hansen-Hagge TE, Bartram CR, Falk S, Gillis S, Hoelzer D, Ganser A. Eder M, et al. Blood. 1992 Jun 15;79(12):3274-84. Blood. 1992. PMID: 1596568 Free article.

3

Regulation of early hematopoiesis in serum-deprived cultures of mafosfamide-treated and untreated CD34-enriched bone marrow cells.

Ottmann OG, Stella CC, Eder M, Reutzel P, Ströcker S, Hoelzer D, Ganser A. Ottmann OG, et al. Among authors: eder m. Exp Hematol. 1991 Sep;19(8):773-8. Exp Hematol. 1991. PMID: 1714403

4

Effects of recombinant human IL-7 on blast cell proliferation in acute lymphoblastic leukemia.

Eder M, Ottmann OG, Hansen-Hagge TE, Bartram CR, Gillis S, Hoelzer D, Ganser A. Eder M, et al. Leukemia. 1990 Aug;4(8):533-40. Leukemia. 1990. PMID: 2388482

5

Purging of peripheral blood stem cells yields BCR-ABL-negative autografts in patients with BCR-ABL-positive acute lymphoblastic leukemia.

Martin H, Atta J, Zumpe P, Eder M, Elsner S, Rode C, Wassmann B, Bruecher J, Hoelzer D. Martin H, et al. Among authors: eder m. Exp Hematol. 1995 Dec;23(14):1612-8. Exp Hematol. 1995. PMID: 8542955 Clinical Trial.

6

Quantification of transforming capacity and cooperation of defined genetic alterations in myeloid malignancies.

Dogan Y, Ganser A, Scherr M, Eder M. Dogan Y, et al. Among authors: eder m. Exp Hematol. 2010 Jan;38(1):11-9. doi: 10.1016/j.exphem.2009.10.006. Exp Hematol. 2010. PMID: 19837127 Free article.

7

Leukemogenic potency of the novel FLT3-N676K mutant.

Huang K, Yang M, Pan Z, Heidel FH, Scherr M, Eder M, Fischer T, Büsche G, Welte K, von Neuhoff N, Ganser A, Li Z. Huang K, et al. Among authors: eder m. Ann Hematol. 2016 Apr;95(5):783-91. doi: 10.1007/s00277-016-2616-z. Epub 2016 Feb 19. Ann Hematol. 2016. PMID: 26891877

8

[In vitro and in vivo effects of recombinant human interleukin-3 on hematopoietic progenitor cells].

Seipelt G, Ottmann OG, Ganser A, Eder M, Lindemann A, Falk S, Stutte HJ, Hübner K, Mertelsmann R, Hoelzer D. Seipelt G, et al. Among authors: eder m. Verh Dtsch Ges Pathol. 1990;74:116-9. Verh Dtsch Ges Pathol. 1990. PMID: 1708567 Clinical Trial. German.

9

Preclinical and clinical evaluation of interleukin 3.

Ganser A, Ottmann OG, Seipelt G, Hess U, Geissler G, Merget R, Falk S, Maurer A, Eder M, Hoelzer D. Ganser A, et al. Among authors: eder m. Behring Inst Mitt. 1991 Dec;(90):50-61. Behring Inst Mitt. 1991. PMID: 1801691 Review. No abstract available.

10

Clinical effects of recombinant human interleukin-3.

Ganser A, Lindemann A, Seipelt G, Ottmann OG, Herrmann F, Eder M, Frisch J, Schulz G, Mertelsmann R, Hoelzer D. Ganser A, et al. Among authors: eder m. Am J Clin Oncol. 1991;14 Suppl 1:S51-63. doi: 10.1097/00000421-199112001-00010. Am J Clin Oncol. 1991. PMID: 2048566 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

791 results

Search Page

Filters